MEDINCELL S.A.
🏢 View company profile →7Patents
7Active
7Granted
55Portfolio score
Filing activity: Jul 17, 2018 → Jun 7, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11801217B2 | Biodegradable block copolymer drug delivery composition | Chemistry; Metallurgy | 0 | Active |
| US12383493B2 | Drug delivery formulations | Human Necessities | 0 | Active |
| US12329851B2 | Long acting injectable formulation comprising risperidone and biodegradable polymers | Human Necessities | 0 | Active |
| US12128132B2 | Drug delivery formulations | Human Necessities | 0 | Active |
| US11865205B2 | Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue | Human Necessities | 0 | Active |
| US12427165B2 | Pharmaceutical composition | Human Necessities | 0 | Active |
| US12220418B2 | Olanzapine compositions and methods of use | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.